Diagnostics
News and analysis on diagnostic technologies and applications.
UK Government Extends Authorization for Innova Medical SARS-CoV-2 Antigen Test
The UK government has extended the timeline of its Exceptional Use Authorization for the Innova lateral flow test, though the FDA has warned about its performance.
Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
The Cobas test is the first molecular, point-of-care test to receive Emergency Use Authorization for asymptomatic people.
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test
SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.
Yourgene Health Awarded £232K Contract to Supply Oncology Genotyping Testing Kits to NHS Wales
Under the two-year contract, Yourgene will supply its Elucigene DPYD testing kits to NHS Wales for the testing of cancer patients prior to chemotherapy.